About Panome Bio
Panome Bio is a company based in St. Louis (United States) founded in 2022. Panome Bio has raised $6 million across 1 funding round from investors including Telegraph Hill Partners and BioGenerator Ventures. Panome Bio offers products and services including Next-Generation Metabolomics, Panome Proteomics, Integrated Multi-omics, Targeted Metabolomics, and Global Phosphoproteomics. Panome Bio operates in a competitive market with competitors including Zifo RnD Solutions, Ephicacy, Conexus, Syne Qua Non and Exploristics, among others.
- Headquarter St. Louis, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6 M (USD)
in 1 rounds
-
Latest Funding Round
$6 M (USD), Series A
Feb 15, 2023
-
Investors
Telegraph Hill Partners
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Panome Bio
Panome Bio offers a comprehensive portfolio of products and services, including Next-Generation Metabolomics, Panome Proteomics, Integrated Multi-omics, Targeted Metabolomics, and Global Phosphoproteomics.
Provides untargeted metabolomics for biomarker discovery and research.
Enables comprehensive proteome profiling for scientific experiments.
Integrates metabolomics and proteomics data for mechanistic insights.
Offers precise quantitative analysis of specific metabolites.
Maps phosphorylation events in unbiased proteome coverage.
People of Panome Bio
Unlock access to complete
Unlock access to complete
Funding Insights of Panome Bio
Panome Bio has successfully raised a total of $6M through 1 strategic funding round. The most recent funding activity was a Series A round of $6 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $6.0M
-
First Round
First Round
(15 Feb 2023)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2023 | Amount | Series A - Panome Bio | Valuation | Telegraph Hill Partners |
Investors in Panome Bio
Panome Bio has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Telegraph Hill Partners and BioGenerator Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on life science, medical device and healthcare companies
|
Founded Year | Domain | Location | |
|
Venture capital and acceleration are provided to life science startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Panome Bio
Financial Statements - Panome Bio
Panome Bio Comparisons
Competitors of Panome Bio
Panome Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zifo RnD Solutions, Ephicacy, Conexus, Syne Qua Non and Exploristics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Clinical data management services are provided to biopharma sector.
|
|
| domain | founded_year | HQ Location |
Biostatistics and statistical programming services are provided for clinical development.
|
|
| domain | founded_year | HQ Location |
Natural gas transmission and storage services are provided in Latvia.
|
|
| domain | founded_year | HQ Location |
Major European functional service provider offering services for data management, EDC, and biostatistics
|
|
| domain | founded_year | HQ Location |
Data analysis and management services are provided to clients.
|
|
| domain | founded_year | HQ Location |
Provider of diversified outsourcing services for pharmaceutical, biotech, and medical device companies
|
Frequently Asked Questions about Panome Bio
Panome Bio was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Panome Bio is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.
Panome Bio is a funded company, having raised a total of $6M across 1 funding round to date. The company's 1st funding round was a Series A of $6M, raised on Feb 15, 2023.
Panome Bio was established in 2022 in St. Louis, United States, within the healthcare technology sector. Clinical data analytics services are delivered to support research and decision-making processes. Operations center on processing and interpreting clinical datasets for various applications. The company maintains its presence through the domain panomebio.com, serving clients in the United States and potentially beyond. Focus remains on factual data handling without additional sectors noted.
Panome Bio's top competitors include Zifo RnD Solutions, Exploristics and Conexus.
Panome Bio offers Next-Generation Metabolomics, Panome Proteomics, Integrated Multi-omics, Targeted Metabolomics, and Global Phosphoproteomics.
Panome Bio has 2 investors. Key investors include Telegraph Hill Partners, and BioGenerator Ventures.